China National Accord Medicines Corporation Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 33,163.091 million compared to CNY 27,169.940 million a year ago. Operating income was CNY 1,137.165 million compared to CNY 1,014.108 million a year ago. Net income was CNY 741.445 million compared to CNY 643.451 million a year ago. Basic earnings per share from continuing operations was CNY 1.73 compared to CNY 1.5 a year ago.